Novel CD4+ T Cell Costimulatory Molecule in Eae

Weinberg, Andrew D.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Neurological Disorders and Stroke (NINDS)
• Type: Research Project (R01)
• Project #: 5R01NS035421-02
• Application #: 2274715
• Study Section: Immunological Sciences Study Section (IMS)
• Project Start: 1995-09-30
• Project End: 1999-07-31
• Budget Start: 1996-08-01
• Budget End: 1997-07-31
• Support Year: 2
• Fiscal Year: 1996

Institution

• Name: Providence Portland Medical Center
• City: Portland
• State: OR
• Country: United States
• Zip Code: 97213

Publications

Weinberg, A D; Wegmann, K W; Funatake, C et al. (1999) Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J Immunol 162:1818-26

Gramaglia, I; Weinberg, A D; Lemon, M et al. (1998) Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 161:6510-7